| Prevalence estimates of amyloid abnormality across the Alzheimer disease clinical spectrum WJ Jansen, O Janssen, BM Tijms, SJB Vos, R Ossenkoppele, PJ Visser, ... JAMA neurology 79 (3), 228-243, 2022 | 167 | 2022 |
| Real-space path integration is impaired in Alzheimer’s disease and mild cognitive impairment I Mokrisova, J Laczo, R Andel, I Gazova, M Vyhnalek, Z Nedelska, ... Behavioural brain research 307, 150-158, 2016 | 73 | 2016 |
| Czech Brain Aging Study (CBAS): prospective multicentre cohort study on risk and protective factors for dementia in the Czech Republic K Sheardova, M Vyhnalek, Z Nedelska, J Laczo, R Andel, R Marciniak, ... BMJ open 9 (12), e030379, 2019 | 53 | 2019 |
| Subjective spatial navigation complaints-a frequent symptom reported by patients with subjective cognitive decline, mild cognitive impairment and alzheimer's disease J Cerman, A Ross, J Laczo, V Martin, N Zuzana, M Ivana, S Katerina, ... Current Alzheimer Research 15 (3), 219-228, 2018 | 52 | 2018 |
| Defining a Centiloid scale threshold predicting long-term progression to dementia in patients attending the memory clinic: an [18F] flutemetamol amyloid PET study BJ Hanseeuw, V Malotaux, L Dricot, L Quenon, Y Sznajer, J Cerman, ... European Journal of Nuclear Medicine and Molecular Imaging 48, 302-310, 2021 | 51 | 2021 |
| Characteristics of subjective cognitive decline associated with amyloid positivity O Janssen, WJ Jansen, SJB Vos, M Boada, L Parnetti, T Gabryelewicz, ... Alzheimer's & Dementia 18 (10), 1832-1845, 2022 | 44 | 2022 |
| Scopolamine disrupts place navigation in rats and humans: a translational validation of the Hidden Goal Task in the Morris water maze and a real maze for humans J Laczó, H Markova, V Lobellova, I Gazova, M Parizkova, J Cerman, ... Psychopharmacology 234, 535-547, 2017 | 41 | 2017 |
| Integrating AI in fighting advancing Alzheimer: Diagnosis, prevention, treatment, monitoring, mechanisms, and clinical trials F Angelucci, AR Ai, L Piendel, J Cerman, J Hort Current Opinion in Structural Biology 87, 102857, 2024 | 7 | 2024 |
| Mild behavioral impairment in early Alzheimer’s disease and its association with APOE and BDNF risk genetic polymorphisms V Matuskova, K Veverova, DJ Jester, V Matoska, Z Ismail, K Sheardova, ... Alzheimer's Research & Therapy 16 (1), 21, 2024 | 7 | 2024 |
| Nové farmakologické možnosti v léčbě Alzheimerovy nemoci. L Kleinová, J Cerman, J Hlávka, J Hort Česká a Slovenská Neurologie a Neurochirurgie 85 (6), 2022 | 6 | 2022 |
| Cerebrospinal fluid ratio of phosphorylated tau protein and beta amyloid predicts amyloid PET positivity J Cerman, J Laczó, M Vyhnálek, J Malinovská, J Hanzalová, J Hort CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE 83 (2), 173-179, 2020 | 6 | 2020 |
| Poměr fosforylovaného tau proteinu k beta amyloidu v likvoru predikuje pozitivitu amyloidové PET. J Cerman, J Laczó, M Vyhnálek, J Malinovská, J Hanzalová, J Hort Česká a Slovenská Neurologie a Neurochirurgie 83 (2), 2020 | 3 | 2020 |
| Differences in spatial navigation impairment in neurodegenerative dementias J Cerman, J Laczó, M Vyhnalek, K Vlcek, O Lerch, K Sheardova, J Hort CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE 77 (4), 449-455, 2014 | 2 | 2014 |
| O5‐03‐06: EGOCENTRIC SPATIAL NAVIGATION IMPAIRMENT IS MORE PRONOUNCED IN AMYLOID POSITIVE MCI PATIENTS: PILOT DATA FROM THE CZECH BRAIN AGEING STUDY J Cerman, J Laczó, M Vyhnalek, M Parizkova, O Belohlavek, J Malinovska, ... Alzheimer's & Dementia 14 (7S_Part_31), P1648-P1648, 2018 | 1 | 2018 |
| The effect of TOMM40 on spatial navigation in amnestic mild cognitive impairment J Laczó, R Andel, K Vlcek, M Vyhnalek, V Matoska, V Kaplan, Z Nedelska, ... Alzheimer's & Dementia 9 (4), P464, 2013 | 1 | 2013 |
| P3‐286: SPATIAL NAVIGATION IMPAIRMENT IS MORE PRONOUNCED IN AMYLOID POSITIVE MCI PATIENTS: DATA FROM THE CZECH BRAIN AGEING STUDY J Cerman, J Laczó, R Andel, M Vyhnalek, M Parizkova, O Belohlavek, ... Alzheimer's & Dementia 15, P1046-P1047, 2019 | | 2019 |
| Clinical utility of amyloid pet in primary progressive aphasia J Cerman, J Laczo, M Vyhnalek, J Malinovska, O Belohlavek, J Hort EUROPEAN JOURNAL OF NEUROLOGY 26, 352-352, 2019 | | 2019 |
| Concordance of amyloid PET and CSF metabolic biomarkers in Alzheimer's disease and how to improve it: data from the Czech Brain Ageing Study J Cerman, J Laczo, M Vyhnalek, O Belohlavek, J Malinovska, ... EUROPEAN JOURNAL OF NEUROLOGY 25, 277-277, 2018 | | 2018 |
| Cerebrospinal fluid ratio of phosphorylated tau protein to beta-amyloid may improve the prediction of amyloid pet positivity: Pilot data from the Czech brain ageing study J Cerman, J Laczó, M Vyhnalek, K Sheardova, J Ferda, O Belohlavek, ... Journal of the Neurological Sciences 381, 320, 2017 | | 2017 |
| [P3–261]: EGOCENTRIC NAVIGATION IMPAIRMENT IS ASSOCIATED WITH FALL RISK IN OLDER ADULTS WITH NEURODEGENERATIVE DEMENTIA J Cerman, J Laczó, M Parizkova, AF Mazancova, O Cakrt, J Hort Alzheimer's & Dementia 13 (7S_Part_21), P1043-P1043, 2017 | | 2017 |
